Publication | Closed Access

Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients

Hematological MalignancyAutoimmune DiseaseMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyHematologyMyeloid NeoplasiaAutoimmunityKiller Immunoglobulin-like ReceptorsTki Treatment-free RemissionAdult T-cell Leukemia-lymphomaRadiation OncologyImmunotherapyCell TransplantationHealth Sciences